AU2003288755C1 - Process for preparing aripiprazole - Google Patents
Process for preparing aripiprazole Download PDFInfo
- Publication number
- AU2003288755C1 AU2003288755C1 AU2003288755A AU2003288755A AU2003288755C1 AU 2003288755 C1 AU2003288755 C1 AU 2003288755C1 AU 2003288755 A AU2003288755 A AU 2003288755A AU 2003288755 A AU2003288755 A AU 2003288755A AU 2003288755 C1 AU2003288755 C1 AU 2003288755C1
- Authority
- AU
- Australia
- Prior art keywords
- aripiprazole
- alkali metal
- carbonate
- formula
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
- C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Psychiatry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Quinoline Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2003-002996 | 2003-01-09 | ||
| JP2003002996 | 2003-01-09 | ||
| PCT/JP2003/016256 WO2004063162A1 (en) | 2003-01-09 | 2003-12-18 | Process for preparing aripiprazole |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| AU2003288755A1 AU2003288755A1 (en) | 2004-08-10 |
| AU2003288755B2 AU2003288755B2 (en) | 2005-08-25 |
| AU2003288755C1 true AU2003288755C1 (en) | 2015-02-19 |
Family
ID=32652780
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2003288755A Ceased AU2003288755C1 (en) | 2003-01-09 | 2003-12-18 | Process for preparing aripiprazole |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US6995264B2 (da) |
| EP (1) | EP1480953B2 (da) |
| JP (2) | JP5797090B2 (da) |
| KR (1) | KR100583667B1 (da) |
| CN (1) | CN1263742C (da) |
| AR (1) | AR042702A1 (da) |
| AT (1) | ATE308524T1 (da) |
| AU (1) | AU2003288755C1 (da) |
| BR (2) | BR0305500A (da) |
| CA (2) | CA2676216A1 (da) |
| DE (1) | DE60302139T3 (da) |
| DK (1) | DK1480953T4 (da) |
| EG (1) | EG23557A (da) |
| ES (1) | ES2250919T5 (da) |
| HK (1) | HK1073110A1 (da) |
| MX (1) | MXPA04002519A (da) |
| MY (1) | MY129831A (da) |
| SI (1) | SI1480953T2 (da) |
| TW (1) | TWI258470B (da) |
| WO (1) | WO2004063162A1 (da) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7714129B2 (en) * | 2003-12-16 | 2010-05-11 | Teva Pharmaceutical Industries Ltd. | Methods of preparing anhydrous aripiprazole form II |
| WO2005058835A2 (en) * | 2003-12-16 | 2005-06-30 | Teva Pharmaceutical Industries Ltd. | Methods of preparing aripiprazole crystalline forms |
| DE202005020539U1 (de) * | 2004-02-05 | 2006-09-28 | Teva Pharmaceutical Industries Ltd. | Aripiprazol |
| US7507823B2 (en) | 2004-05-06 | 2009-03-24 | Bristol-Myers Squibb Company | Process of making aripiprazole particles |
| JP4819818B2 (ja) * | 2004-10-08 | 2011-11-24 | スベン ライフ サイエンシズ リミティド | アリピプラゾールの製造方法、並びに対応する中間体及びそれらの製造 |
| US20060079689A1 (en) * | 2004-10-12 | 2006-04-13 | Vladimir Naddaka | Processes for preparing and purifying carbostyril compounds such as aripiprazole and 7-(4-halobutoxy)-3,4-dihydro-2(1H)-quinolinones |
| CN101111481A (zh) * | 2004-11-18 | 2008-01-23 | 斯索恩有限公司 | 制备结晶阿立哌唑的方法 |
| CN1303068C (zh) * | 2005-01-11 | 2007-03-07 | 中国人民解放军第二军医大学 | 一种阿立哌唑的制备方法 |
| TWI320783B (en) | 2005-04-14 | 2010-02-21 | Otsuka Pharma Co Ltd | Heterocyclic compound |
| CA2622758A1 (en) | 2005-09-15 | 2007-03-29 | Elan Pharma International, Limited | Nanoparticulate aripiprazole formulations |
| JP2008537540A (ja) * | 2005-12-22 | 2008-09-18 | テバ ファーマシューティカル インダストリーズ リミティド | アリピプラゾールの粒径を小さくする方法 |
| US20070149782A1 (en) * | 2005-12-23 | 2007-06-28 | Michael Brand | Methods of preparing a crystalline form of 7-(4-chlorobutoxy)-3,4-dihydro-2(1h)-quinolinone and the use thereof in the synthesis of Aripiprazole |
| US20070238876A1 (en) * | 2006-04-10 | 2007-10-11 | Neera Tewari | Process for the preparation of aripiprazole |
| BRPI0811844A2 (pt) | 2007-05-21 | 2014-11-18 | Reviva Pharmaceuticals Inc | Composto, e, método para tratar um paciente |
| US8207163B2 (en) | 2008-05-27 | 2012-06-26 | Reviva Pharmaceuticals, Inc. | Compositions, synthesis, and methods of using piperazine based antipsychotic agents |
| CN101781246B (zh) * | 2009-01-15 | 2012-02-29 | 成都康弘药业集团股份有限公司 | 一种合成阿立哌唑的改进方法 |
| US8575185B2 (en) | 2009-02-26 | 2013-11-05 | Reviva Pharmaceuticals, Inc. | Compositions, synthesis, and methods of utilizing quinazolinedione derivatives |
| JOP20200109A1 (ar) | 2012-04-23 | 2017-06-16 | Otsuka Pharma Co Ltd | مستحضر قابل للحقن |
| US20180155290A1 (en) * | 2015-05-08 | 2018-06-07 | Davuluri Ramamohan Rao | Improved Process for the Preparation of Aripiprazole with Reduced Particle Size |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS54130587A (en) * | 1978-03-30 | 1979-10-09 | Otsuka Pharmaceut Co Ltd | Carbostyryl derivative |
| DE3034237A1 (de) † | 1979-09-18 | 1981-04-16 | Otsuka Pharmaceutical Co. Ltd., Tokyo | Carbostyrilderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende, antihistaminisch wirkende mittel |
| JP2608788B2 (ja) * | 1988-10-31 | 1997-05-14 | 大塚製薬 株式会社 | 精神分裂病治療剤 |
| US5006528A (en) * | 1988-10-31 | 1991-04-09 | Otsuka Pharmaceutical Co., Ltd. | Carbostyril derivatives |
| JP4060523B2 (ja) † | 1999-11-24 | 2008-03-12 | 大塚製薬株式会社 | カルボスチリル誘導体の製造法 |
| AR033485A1 (es) † | 2001-09-25 | 2003-12-26 | Otsuka Pharma Co Ltd | Sustancia medicinal de aripiprazol de baja higroscopicidad y proceso para la preparacion de la misma |
-
2003
- 2003-12-18 TW TW092135997A patent/TWI258470B/zh not_active IP Right Cessation
- 2003-12-18 CA CA002676216A patent/CA2676216A1/en not_active Abandoned
- 2003-12-18 AU AU2003288755A patent/AU2003288755C1/en not_active Ceased
- 2003-12-18 CA CA002458929A patent/CA2458929C/en not_active Expired - Fee Related
- 2003-12-18 DK DK03780889.6T patent/DK1480953T4/da active
- 2003-12-18 SI SI200330153T patent/SI1480953T2/sl unknown
- 2003-12-18 KR KR1020047003990A patent/KR100583667B1/ko active IP Right Grant
- 2003-12-18 WO PCT/JP2003/016256 patent/WO2004063162A1/en active IP Right Grant
- 2003-12-18 BR BR0305500-0A patent/BR0305500A/pt not_active IP Right Cessation
- 2003-12-18 ES ES03780889T patent/ES2250919T5/es not_active Expired - Lifetime
- 2003-12-18 DE DE60302139T patent/DE60302139T3/de not_active Expired - Lifetime
- 2003-12-18 MX MXPA04002519A patent/MXPA04002519A/es active IP Right Grant
- 2003-12-18 EP EP03780889A patent/EP1480953B2/en not_active Expired - Lifetime
- 2003-12-18 AT AT03780889T patent/ATE308524T1/de active
- 2003-12-18 BR BRPI0305500-0A patent/BRPI0305500B1/pt unknown
-
2004
- 2004-01-05 EG EG2004010004A patent/EG23557A/xx active
- 2004-01-05 AR ARP040100006A patent/AR042702A1/es not_active Application Discontinuation
- 2004-01-08 US US10/752,490 patent/US6995264B2/en active Active
- 2004-01-08 MY MYPI20040043A patent/MY129831A/en unknown
- 2004-01-09 CN CNB2004100020641A patent/CN1263742C/zh not_active Expired - Lifetime
-
2005
- 2005-07-11 HK HK05105804A patent/HK1073110A1/xx not_active IP Right Cessation
-
2011
- 2011-11-04 JP JP2011241871A patent/JP5797090B2/ja not_active Expired - Lifetime
-
2014
- 2014-03-06 JP JP2014043786A patent/JP2014148511A/ja active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2003288755C1 (en) | Process for preparing aripiprazole | |
| US5006528A (en) | Carbostyril derivatives | |
| JPH02191256A (ja) | カルボスチリル誘導体及び該誘導体を含有する精神分裂病治療剤 | |
| CA2255333C (en) | Quinolinone derivative, method for preparing the same, and anti-allergic agent | |
| RU2384572C2 (ru) | Соли арипипразола | |
| EP1845088B1 (en) | An improved process for the preparation of aripipirazole | |
| EP1682539B1 (en) | Process for preparing thiazolidinediones | |
| JPS6338005B2 (da) | ||
| JP4060523B2 (ja) | カルボスチリル誘導体の製造法 | |
| WO2008026220A1 (en) | A process for purification of 7-(4-bromobutoxy)-3,4 dihydrocarbostyril, an intermediate for manufacture of aripirazole | |
| JP4902945B2 (ja) | アリピプラゾールの製造法 | |
| US20030045547A1 (en) | Process for producing carbostyril derivatives | |
| EP2874628A2 (en) | Salts and hydrates of antipsychotics | |
| US5059607A (en) | Imidazolyl benzisoquinolines useful as 5-ht3 receptor antagonists | |
| JPH068284B2 (ja) | ３−チオキソ−ベンゾチアジン誘導体 | |
| US5972945A (en) | 2-aminoalkylaminoquinolines; dopamine receptor subtype specific ligands | |
| JPH07304740A (ja) | カルボスチリル誘導体 | |
| JPH07165720A (ja) | カルボスチリル誘導体及び該誘導体を含有する精神分裂病治療剤 | |
| US6613901B2 (en) | 2-aminoalkylaminoquinolines as dopamine D4 ligands | |
| KR100210006B1 (ko) | 7-치환된피페라지닐 아미노-3-퀴놀론카르복실산 유도체 및 그의 제조방법 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FGA | Letters patent sealed or granted (standard patent) | ||
| DA2 | Applications for amendment section 104 |
Free format text: THE NATURE OF THE AMENDMENT IS AS SHOWN IN THE STATEMENT(S) FILED 10 OCT 2014 . |
|
| DA3 | Amendments made section 104 |
Free format text: THE NATURE OF THE AMENDMENT IS AS SHOWN IN THE STATEMENT(S) FILED 10 OCT 2014 |
|
| MK14 | Patent ceased section 143(a) (annual fees not paid) or expired |